Abstract:Late-onset hemorrhagic cystitis (LOHC) is a common complication following allogeneic hematopoietic stem cell transplantation (allo-HSCT), which was mainly associated with BK virus and adenovirus (ADV). However, there still some patients developed LOHC without infection of BKV and ADV. Several retrospective studies showed that CMV infection was associated with LOHC. So, we design this prospective study to define the relationship between CMV infection and LOHC. Fifty consecutive patients who received allo-HSCT between October 2011 and December 2011 were prospectively investigated to screen BKV, ADV and CMV in the urine and plasma using Real-time Polymerase Chain Reaction (RT-PCR). Twenty-one out of the 50 patients developed LOHC with a cumulative incidence of 42%±7.1%.The median time from transplantation to onset of LOHC was 29 (range, 4-64) days. There are 34 patients and 21 patients developed CMV viremia and CMV viruria, respectively, within day 100. The cumulative incidence of LOHC in patients with CMV viremia was significantly higher than those without CMV viremia (58.8% vs. 6.3%, P = .001) on day 100 after transplantation. Patients with CMV viruria had a significant higher cumulative incidence of LOHC than those without CMV viruria (60.7% vs. 18.2%, P = .006). The cumulative incidence of CMV viremia and CMV viruria in patients with LOHC (n=21) versus those without LOHC (n=29) were 95.2% vs. 48.3% (P = .001) and 80.9% vs. 34.5% (P = .001), respectively. The cumulative incidence of LOHC in patients whose plasma BKV load increased more than or equal to 103-fold over baseline was significantly higher than those with plasma load increase less than 103-fold (67.9%±9.2%vs. 9.1%±6.3%, P < .001). The cumulative incidence of LOHC in patients whose urine BKV load increased more than or equal to 104-fold over baseline was significantly higher than those with urine load increase less than 104-fold (66.7% ±10.3% vs. 19.2%±7.9%, P = .002). ADV was positive in 4 patients including one patient with LOHC. Multivirariate analysis showed that CMV viremia (HR=10.496, 95% CI: 1.527-86.570, P = .018) and plasma BKV load increased more than or equal to 103-fold compared to baseline level (HR=10.669, 95% CI: 2.452-46.419, P = .002) were two independent risk factors for LOHC. Our data suggest that CMV viremia is a risk factor for LOHC following allo-HSCT.

[Correlation Between Load of Polyomavirus and Hemorrhagic Cystitis].

The prevalence and isolated subtypes of BK polyomavirus reactivation among patients infected with human immunodeficiency virus-1 in southeastern China

Incidence, risk factors and the effect of polyomavirus infection in hematopoietic stem cell transplant recipients.

Detection and Analysis of Variants of JC Polyomavirus in Urine Samples from HIV-1-infected Patients in China’s Zhejiang Province

Progress on the association between human gene polymorphisms and cytomegalovirus infection after transplantation

Cytomegalovirus Viremia is a Risk Factor for Late-Onset Hemorrhagic Cystitis Following Allogeneic Hematopoietic Stem Cell Transplantation

Prevalence Of Jc Virus In Chinese Patients With Colorectal Cancer

Prospective Study of Posttransplant Polyomavirus Infection in Renal Transplant Recipients.

Cytomegalovirus is a Potential Risk Factor for Late‐onset Hemorrhagic Cystitis Following Allogeneic Hematopoietic Stem Cell Transplantation

Clinical Impact of BK Viremia during Haploidentical Stem Cell Transplantation and Its Association with Hemorrhagic Cystitis

Urinary donor-derived cell-free DNA as a non-invasive biomarker for BK polyomavirus-associated nephropathy

An Application of the 2018 Banff Classification for BK Polyomavirus-Associated Nephropathy in Renal Transplantation.

Decreased lymphocyte count before conditioning is associated with BK virus-associated hemorrhagic cystitis after allogeneic hematopoietic stem cell transplantation

Quantitative Monitoring of Blood Cytomegalovirus after Allogeneic Hematopoietic Stem Cell Transplantation and Its Clinical Significance

BK virus associated nephropathy after kidney transplantation

Dectection and risk factor analysis of cytomegalovirus infection after allogeneic hematopoietic stem cell transplantation

Pathological characteristics of BK polyomavirus-associated nephropathy with glomerular involvement

Hemorrhagic Cystitis Following Hematopoietic Stem Cell Transplantation: Incidence, Risk Factors and Association with CMV Reactivation and Graft-Versus-host Disease

[Cytomegalovirus Diseases after Allogeneic Hematopoietic Stem Cell Transplantation (Allo-Hsct) and Related Risk Factors].

Gut Microbiota Dysbiosis in BK Polyomavirus-Infected Renal Transplant Recipients: A Case-Control Study

[Relationship between copies of cytomegalovirus in plasma and cytomegalovirus disease after allogeneic hematopoietic stem cell transplantation].